key: cord-1025129-o3bryc7u
authors: Zhu, Jian; Zhang, Yu; Gao, Xu-Hui; Xi, Er-Ping
title: COVID-19 or Lung Cancer: A differential diagnostic experience and management model from Wuhan
date: 2020-05-07
journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
DOI: 10.1016/j.jtho.2020.04.030
sha: bf1676b76a6aa3338033de3e3ed70e88e12420a6
doc_id: 1025129
cord_uid: o3bryc7u

nan

In the Journal of Thoracic Oncology, Sufang Tian and colleagues reported one of the patients died of COVID-19 after lung lobectomy for adenocarcinoma 1 We took the following measures to exclude of them. First, the patients to be admitted to the hospital were asked about their medical history in detail, including the contact history of COVID-19 and whether they had fever, cough, diarrhea, sore throat or other symptoms in the past 2 weeks. After taking the medical history, the patient signed a form promising to disclose their medical history without any concealment; otherwise, the patient will bear legal responsibility. Second, chest CT examination, routine blood parameter and blood IgG and IgM analyses, and nucleic acid examination of pharyngeal swab specimens were performed on the patients and their escorts when they were admitted to the hospital.

Third, only the escorts of the patient who passed the above test with negative results were allowed to accompany the patient, and a minimum number of people were allowed to accompany the patient.

If the patient was diagnosed as having suspected COVID-19 in the above examination, they were admitted to the suspected COVID-19 ward for further investigation. If the diagnosis was confirmed, the patient was transferred to the infected area for treatment. Fourth, newly admitted patients were placed in protective isolation in single rooms. After repeated monitoring of body temperature by medical professionals, if there were no abnormalities and none of the symptoms mentioned above were present, then 24 hours later, the patient was given a second pharyngeal swab for nucleic acid examination. If negative, the patient was transferred to the general ward for 2-3 days. Patient indicator information of COVID-19 will be announced in the department medical staffs' WeChat group announcement and updated daily. Fifth, hospitalized patients wore masks at all times, and visitors as well as exchanges with other patients were strictly prohibited. Sixth, the suspected COVID-19 and general wards in the department were managed independently by staff, and the staff were strictly prohibited to change across wards.

They also need to maintain strict protective measures among themselves, such as wearing a mask if two or more people sleep in the same duty room. Seventh, patients going out for checks or eating were assigned a special route, and there was regular professional disinfection. Eighth, routine bronchoscopy was performed before lung surgery, and nucleic acid examination was performed, along with an analysis of the secretions from the lower respiratory tract.

Ninth, after several days (generally 1-2 week) of examination and surgical preparation, lung cancer patients with no evidence of COVID-19 underwent routine operation.

Competing interests: The authors have declared no competing interests.

Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer

A rapid fatal evolution of Coronavirus Disease-19 (COVID-19) in an advanced lung cancer patient with a long time response to nivolumab

COVID-19 or Lung Cancer: what should we treat?

Alert to Potential Contagiousness: A Case of Lung Cancer with Asymptomatic SARS-CoV-2 Infection

CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan